On March 20, 2024, the European Patent Office (EPO) officially granted Cognes Medical Solutions AB a patent for its novel method and system for non-invasive estimation of dementia progression. This novel approach, which utilizes imaging technology to capture and analyze images of a subject’s head from various angles, has the potential to improve early detection […]
While the Cognes app is not a replacement for a registered medical practitioner’s diagnosis, it is a valuable tool in identify early-stage Dementia patients.
Amazing Breakthroughs in Dementia & Alzheimer’s treatment & diagnosis Read More »
One of the most significant causes of dementia in the modern world is Alzheimer’s. Yet even though many people are suffering from this terrible disease, there are many challenges in diagnosing Alzheimer’s dementia. Often this is because many of the common symptoms that show up early tend to correspond with other disorders within the neurodegenerative disorder family.
Assessing Memory Impairment: Alzheimer’s Diagnostics and Treatments of the Future Read More »
Alzheimer’s disease is one of the most common forms of dementia. Many people wonder if Alzheimer’s disease is preventable. Based on extensive research, many factors contribute to the development of the disease. This includes environmental factors, genetics, age, and existing medical conditions. Many risk factors, like genetics and age, can’t be changed.
Effects Of Alzheimer’s Disease On The Brain Read More »
Alzheimer’s disease is one of the most common forms of dementia. Many people wonder if Alzheimer’s disease is preventable. Based on extensive research, many factors contribute to the development of the disease. This includes environmental factors, genetics, age, and existing medical conditions. Many risk factors, like genetics and age, can’t be changed.
How to Reduce The Risk Of Alzheimer’s Disease Read More »
Today, Alzheimer’s is one of the most prevalent diseases in America, affecting about 11.3% of all people aged 65 years and over. In 2021, there were about 6.2 million people with Alzheimer’s, with the number expected to more than double and reach 13 million by 2050 should a cure not be found. It typically affects the seniors, with 72% of the 6.2 million people living with Alzheimer’s being over 75 years old.
Unraveling Alzheimer’s: Confronting the Effect on Mortality Read More »
In 2021, more than 6 million people were living with Alzheimer’s in the US. This number is projected to more than double to over 13 million by 2050. Despite the exceedingly high number of Alzheimer’s patients, the cost of diagnosis and treatment is also very high, making it one of the costliest ailments in the world. As a result, proper diagnosis and treatment are way off the reach of thousands of Americans, with this number also projected to rise.
Alzheimer’s Diagnosis Accessibility: A Need for Earlier Diagnosis and a Better Life Read More »
In 2021 in the United States, about 6.2 million people above the age of 65 were living with Alzheimer’s. As the nation progressively gets older, this number is expected to more than double to 13 million by 2050. People living with Alzheimer’s make up 11.3% of all people over the age of 65.
The Cost of Alzheimer’s on the Mind, Soul and Bank Account Read More »
According to the Alzheimer’s Association, more than 6 million Americans aged 65 years and older live with Alzheimer’s. This number is expected to more than double, hitting about 13 million people by 2050. This translated to about one in nine people over the age of 65, or 11.3% of Americans have dementia. And the numbers are just as staggering around the globe.
Alzheimer’s and the Benefits of Early Diagnosis Read More »
Alzheimer’s disease is a disease in which the brain’s neurons slowly become damaged, causing cognitive issues like memory loss, loss of social behaviors, and loss of language. Many people with Alzheimer’s end up not being able to recognize their loved ones. Eventually, the disease is fatal.
Empowering Lives Through Early Detection and Management of Alzheimer’s Read More »
